Saladax Biomedical, Inc. 5-FU Fact Sheet
Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy Therapeutic Drug Monitoring (TDM) Test
May 14, 2024 10:00 ET | Saladax Biomedical, Inc.
Bethlehem, PA, May 14, 2024 (GLOBE NEWSWIRE) -- Saladax Biomedical, Inc. (Saladax) is pleased to announce that Health Canada has approved Saladax’s 5-Fluorouracil (My5-FU) Assay for sale in Canada...
Custom Designed UV Viewing Systems
June 11, 2015 11:33 ET | Spectronics Corporation
WESTBURY, NY--(Marketwired - June 11, 2015) - The Spectroline® CC-80 and CC-81 ultraviolet viewing systems provide unequaled fluorescence analysis of research findings. The CC-80 and CC-81 are ideal...
Children's Tumor Foundation logo
Media Alert: Innovative Business Opportunities in Neurofibromatosis
June 09, 2014 10:19 ET | Children's Tumor Foundation
NEW YORK, N.Y., June 9, 2014 (GLOBE NEWSWIRE) -- The Children's Tumor Foundation (CTF) is hosting the 2014 NF Conference, the largest worldwide meeting dedicated entirely to neurofibromatosis (NF), a...